General Information of the Compound
Compound ID
CP0910624
Compound Name
(2S,5S,8S,11S,14S,17S,20S,23S,26S,29S,32S,35S,38S,41S,44S,47S,50S,56S,59S,62S,65S,68S,71S,74S,77S,80S,83S,86S,92S)-26-((1H-indol-3-yl)methyl)-92-(2-((S)-2-amino-3-(1H-imidazol-5-yl)propanamido)acetamido)-17,50,62-tris(3-amino-3-oxopropyl)-11,65-bis(4-aminobutyl)-35,83-dibenzyl-8,20,32-tri-sec-butyl-29,56-bis(2-carboxyethyl)-38,74-bis(carboxymethyl)-41-(3-guanidinopropyl)-5,14,80,86-tetrakis((R)-1-hydroxyethyl)-68,77-bis(hydroxymethyl)-23,71-diisobutyl-44-isopropyl-47-methyl-59-(2-(methylthio)ethyl)-4,7,10,13,16,19,22,25,28,31,34,37,40,43,46,49,52,55,58,61,64,67,70,73,76,79,82,85,88,91-triacontaoxo-3,6,9,12,15,18,21,24,27,30,33,36,39,42,45,48,51,54,57,60,63,66,69,72,75,78,81,84,87,90-triacontaazatetranonacontane-1,2,94-tricarboxylic acid
    Show/Hide
Structure
Formula
C166H258N44O55S
Molecular Weight
3782.21
Canonical SMILES
CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@@H](N)Cc1cnc[nH]1)[C@@H](C)O)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)O)[C@@H](C)O)[C@@H](C)CC)[C@@H](C)O)[C@@H](C)CC
    Show/Hide
InChI
InChI=1S/C166H258N44O55S/c1-19-81(10)129(158(257)191-103(46-52-118(172)219)147(246)208-133(86(15)214)162(261)190-97(42-31-33-58-168)146(245)205-131(83(12)21-3)160(259)210-135(88(17)216)163(262)200-113(165(264)265)69-127(233)234)206-152(251)107(62-79(6)7)194-149(248)110(65-91-70-177-95-40-29-28-39-93(91)95)196-144(243)104(49-55-124(227)228)192-159(258)130(82(11)20-2)207-153(252)108(63-89-35-24-22-25-36-89)195-151(250)111(67-125(229)230)197-142(241)98(43-34-59-176-166(173)174)189-157(256)128(80(8)9)204-136(235)84(13)182-140(239)101(44-50-116(170)217)184-120(221)73-179-139(238)100(48-54-123(225)226)186-145(244)105(56-60-266-18)188-143(242)102(45-51-117(171)218)187-141(240)96(41-30-32-57-167)185-155(254)114(75-211)201-148(247)106(61-78(4)5)193-150(249)112(68-126(231)232)198-156(255)115(76-212)202-164(263)134(87(16)215)209-154(253)109(64-90-37-26-23-27-38-90)199-161(260)132(85(14)213)203-121(222)74-180-138(237)99(47-53-122(223)224)183-119(220)72-178-137(236)94(169)66-92-71-175-77-181-92/h22-29,35-40,70-71,77-88,94,96-115,128-135,177,211-216H,19-21,30-34,41-69,72-76,167-169H2,1-18H3,(H2,170,217)(H2,171,218)(H2,172,219)(H,175,181)(H,178,236)(H,179,238)(H,180,237)(H,182,239)(H,183,220)(H,184,221)(H,185,254)(H,186,244)(H,187,240)(H,188,242)(H,189,256)(H,190,261)(H,191,257)(H,192,258)(H,193,249)(H,194,248)(H,195,250)(H,196,243)(H,197,241)(H,198,255)(H,199,260)(H,200,262)(H,201,247)(H,202,263)(H,203,222)(H,204,235)(H,205,245)(H,206,251)(H,207,252)(H,208,246)(H,209,253)(H,210,259)(H,223,224)(H,225,226)(H,227,228)(H,229,230)(H,231,232)(H,233,234)(H,264,265)(H4,173,174,176)/t81-,82-,83-,84-,85+,86+,87+,88+,94-,96-,97-,98-,99-,100-,101-,102-,103-,104-,105-,106-,107-,108-,109-,110-,111-,112-,113-,114-,115-,128-,129-,130-,131-,132-,133-,134-,135-/m0/s1
    Show/Hide
InChIKey
BLGOHZGXVGYXFT-XOFHTFFPSA-N
Physicochemical Property
logP
-16.51513
Rotatable Bonds
129
Heavy Atom Count
266
Polar Areas
1627.38
Hydrogen Bond Donor Count
56
Hydrogen Bond Acceptor Count
54
Complexity
266

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 145988475
ChEMBL ID
CHEMBL4290760
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01356, Glucagon-like peptide 1 receptor
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000006 HEK293 Homo sapiens (Human)  1
1
EC50 = 1 nM
   TI
   LI
   LO
   TS
Protein ID: PT05688, Glucagon-like peptide 2 receptor
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000006 HEK293 Homo sapiens (Human)  1
1
EC50 = 0.2 nM
   TI
   LI
   LO
   TS